Replies to post #295789 on Avid Bioservices Inc (CDMO)

[swg_tdr]

CP, thanks, new middle class exactly, and that's why even in the USA you have to start the market with "trendsetters"

Note how in the people I interviewed, the entrepreneur went for the "worth $3000 annually check-up" in a flash, and settled for $300, while others were mamby pamby about needing it at any price. Hence, a 33% market penetration assumed for the USA.

I have some stats on scans per capita for different countries, indicating that Japan (and S Korea) is a high spenders for health, and my brief exposure to Japanese led me to guess a 90% (age bracket) participation. I believe they still smoke, as do the Chinese and Koreans, so they are more cancer aware, IMO.

Anyway, it all comes down to market introduction and time frame, as well as initial pricing -- and management and as such we should spin off the IP and value it via an IPO.

Would instantly reflect on the PPHM shareprice, IMO.

best,